Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 30, 2023
Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomesMelissa Amrein, Stephanie Meier, Ibrahim Schäfer, et al.
Brain : a Journal of Neurology|May 15, 2020
Neurofilaments: neurobiological foundations for biomarker applicationsArie R Gafson, Nicolas R Barthélemy, Pascale Bomont, et al.
BMJ Neurology Open|April 18, 2025
Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosisDaniel E Radford-Smith, Abi G Yates, Tereza Kacerova, et al.
Plos One|September 28, 2013
Increased neurofilament light chain blood levels in neurodegenerative neurological diseasesJohanna Gaiottino, Niklas Norgren, Ruth Dobson, et al.
Journal of Neurology|November 27, 2019
A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosisEleonora Tavazzi, Niels Bergsland, Jens Kuhle, et al.
Communications Medicine|February 25, 2026
Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progressionTereza Kacerova, Eline Willemse, Johanna Oechtering, et al.
Neurology|February 13, 2020
Blood neurofilament light levels segregate treatment effects in multiple sclerosisBénédicte Delcoigne, Ali Manouchehrinia, Christian Barro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2014
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcomeJens Kuhle, Johanna Gaiottino, David Leppert, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 20, 2020
Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal studyEleonora Tavazzi, Dejan Jakimovski, Jens Kuhle, et al.
Pageof 16